DOA
NVO

D'Orazio & Associates’s Novo Nordisk NVO Stock Holding History

D'Orazio & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,852
Closed -$214K – 294
2025
Q3 		$214K Sell
3,852
-1,353
-26% -$79.2K 0.03% 246
2025
Q2 		$359K Sell
5,205
-731
-12% -$49.7K 0.05% 146
2025
Q1 		$412K Sell
5,936
-2,313
-28% -$191K 0.06% 119
2024
Q4 		$710K Sell
8,249
-401
-5% -$43.4K 0.1% 70
2024
Q3 		$1.03M Sell
8,650
-74
-0.8% -$9.87K 0.15% 56
2024
Q2 		$1.25M Buy
8,724
+69
+0.8% +$9.14K 0.19% 43
2024
Q1 		$1.11M Buy
8,655
+362
+4% +$43.1K 0.18% 46
2023
Q4 		$858K Buy
8,293
+1,159
+16% +$115K 0.15% 54
2023
Q3 		$649K Buy
7,134
+1,118
+19% +$98.5K 0.15% 60
2023
Q2 		$487K Sell
6,016
-786
-12% -$64.2K 0.11% 65
2023
Q1 		$541K Sell
6,802
-190
-3% -$13.5K 0.14% 57
2022
Q4 		$473K Buy
6,992
+956
+16% +$56K 0.11% 69
2022
Q3 		$301K Sell
6,036
-352
-6% -$18.9K 0.09% 90
2022
Q2 		$356K Buy
6,388
+2,020
+46% +$112K 0.09% 76
2022
Q1 		$243K Buy
+4,368
New +$224K 0.06% 88
2021
Q4 		– Sell
-1,326
Closed -$64K – 502
2021
Q3 		$64K Buy
+1,326
New +$64.1K 0.02% 173
2015
Q4 		– Sell
-560
Closed -$15K – 298
2015
Q3 		$15K Buy
+560
New +$15.9K 0.01% 167

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D'Orazio & Associates's NVO Position: Q4 2025 in Review

D'Orazio & Associates sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,852 shares — an estimated $214K sold.

D'Orazio & Associates first reported a position in NVO in Q3 2015 and held it in 17 quarters. The position peaked at $1.25M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • D'Orazio & Associates reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • D'Orazio & Associates sold 3,852 Novo Nordisk shares in Q4 2025, an estimated $214K.
  • D'Orazio & Associates first reported a position in Novo Nordisk in Q3 2015 and held it in 17 quarters.
  • D'Orazio & Associates's Novo Nordisk position peaked at $1.25M in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on D'Orazio & Associates's 13F filing for Q4 2025, filed 4 Feb 2026.